IMRT-MC2 Trial: Comparing Two Radiotherapy Techniques for Breast Cancer
Author Information
Author(s): Askoxylakis Vasileios, Jensen Alexandra D, Häfner Matthias F, Fetzner Leonie, Sterzing Florian, Heil Joerg, Sohn Christof, Hüsing Johannes, Tiefenbacher Uta, Wenz Frederik, Debus Jürgen, Hof Holger
Primary Institution: University of Heidelberg
Hypothesis
Is intensity modulated radiotherapy (IMRT) at least equivalent to conventional therapy in terms of cosmetic outcome and local control despite a reduced treatment duration?
Conclusion
The study aims to evaluate whether IMRT can provide similar or better outcomes compared to conventional radiotherapy while reducing treatment time.
Supporting Evidence
- The study will evaluate cosmetic results and local control rates at 6 weeks and 2 years post-treatment.
- Secondary objectives include overall survival, disease-free survival, and quality of life assessments.
Takeaway
This study is looking at two ways to give radiation to breast cancer patients to see if one way is better and faster than the other.
Methodology
A prospective, two-armed, multicenter, randomized phase-III trial comparing IMRT with integrated boost to conventional radiotherapy with consecutive boost.
Limitations
The study may have limitations related to patient selection and the generalizability of the results.
Participant Demographics
Patients aged >18 years and <70 years after breast conserving surgery, with specific risk factors for those aged ≥70.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website